Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis

Background: A malfunction in the melanocortin-4 receptor (MC4R) is associated with obesity in rare genetic syndromes; setmelanotide is a new drug that activates this receptor and is being used to treat severe obesity. This meta-analysis evaluated the efficacy and safety of setmelanotide for weight l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraz Barbosa, Bárbara, Aquino de Moraes, Francisco Cezar, Bordignon Barbosa, Camila, Palavicini Santos, Plínio Takashi Karubi, Pereira da Silva, Izael, Araujo Alves da Silva, Bruno, Cristine Marques Barros, Jamile, Rodríguez Burbano, Rommel Mario, Pereira Carneiro dos Santos, Ney, Rodrigues Fernandes, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608339/
https://www.ncbi.nlm.nih.gov/pubmed/37888071
http://dx.doi.org/10.3390/jpm13101460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608339/
https://www.ncbi.nlm.nih.gov/pubmed/37888071
http://dx.doi.org/10.3390/jpm13101460

Ejemplares similares